Do meal replacement drinks have a role in diabetes management?

被引:8
|
作者
Ditschuneit, Herwig H. [1 ]
机构
[1] Univ Ulm Klinikum, Med Klin, DE-89081 Ulm, Germany
关键词
D O I
10.1159/000094450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The poor effectiveness of conventional dietary treatment for weight loss and weight maintenance in patients with type-2 diabetes may be improved by a meal replacement strategy that provides a strong structured meal plan with reasonable opportunity for dietary variety. Typical meal replacement programs fix the intake of one or two meals per day with a calorie-controlled, nutritionally balanced commercial formulation, and allow prudent additional meals and snacks. In obese subjects, diets with meal replacements have proven to be more efficient than conventional diets. Patients on the meal replacement regimen lost 7.3 and 8.4% of initial body weight after 12 weeks and 4 years, respectively, whereas the patients on the conventional diet had lost 1.4% and 3.2% of initial body weight after 12 weeks and 4 years, respectively. The meal replacement plan has also proven to be effective in patients with type-2 diabetes. After 6 and 12 months, patients in the meal replacement group achieved on average a weight loss of 5.24 and 4.35% of their initial body weight, respectively. In contrast, after 6 and 12 months, patients on the individualized diet plan achieved on average a weight loss of 2.85 and 2.36% of their initial body weight, respectively. Meal replacements offer a promising strategy for treating obese patients with type-2 diabetes. Copyright (c) 2006 Nestec Ltd.
引用
收藏
页码:171 / 181
页数:11
相关论文
共 50 条
  • [31] XENOGRAFTS - DO THEY HAVE A ROLE
    FOX, IJ
    SINDHI, R
    SHAW, BW
    BAILLIERES CLINICAL GASTROENTEROLOGY, 1994, 8 (03): : 441 - 454
  • [32] Efficacy and Safety of Meal Replacement in Patients With Type 2 Diabetes
    Ye, Wenjing
    Xu, Lijuan
    Ye, Yanbin
    Zeng, Fangfang
    Lu, Xin
    Li, Yanbing
    Liu, Liehua
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : 3041 - 3049
  • [33] Do immunotherapy and β cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li, Dong-Sheng
    Warnock, Garth L.
    Tu, Han-Jun
    Ao, Ziliang
    He, Zehua
    Lu, Hong
    Dai, Long-Jun
    LIFE SCIENCES, 2009, 85 (15-16) : 549 - 556
  • [34] Do practice nurses have the knowledge to provide diabetes self-management education?
    Hollis, Margaret
    Glaister, Karen
    Lapsley, Jennifer Anne
    CONTEMPORARY NURSE, 2014, 46 (02) : 234 - 241
  • [35] Glycoprotein IIB/IIIA antagonists: Do they have a role in the management of unstable angina?
    Redwood, S
    Marber, M
    Jackson, G
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (08) : 618 - 622
  • [36] Molecular Techniques in the Diagnosis and Management of Infectious Diseases: Do They Have a Role in Bacteriology?
    Poxton, Ian R.
    MEDICAL PRINCIPLES AND PRACTICE, 2005, 14 : 20 - 26
  • [37] Do Botulinum Toxins Have a Role in the Management of Neuropathic Pain? A Focused Review
    Francisco, Gerard E.
    Tan, Huaiyu
    Green, Michael
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2012, 91 (10) : 899 - 909
  • [38] Do Pharmacists Have a Role in Recommending Codeine for Pain Management? Australian Perspectives
    Carroll, Peter R.
    Moles, Rebekah
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2016, 69 (06): : 501 - 502
  • [39] Do videolaryngoscopes have a new role in the SIAARTI difficult airway management algorithm?
    Frova, G.
    MINERVA ANESTESIOLOGICA, 2010, 76 (08) : 637 - 640
  • [40] Do antibodies have an influence on enzyme replacement therapy?
    Frenking, G. Schulze
    Arash, L.
    Mengel, E.
    Beck, M.
    CLINICAL THERAPEUTICS, 2007, 29 : S128 - S128